https://doi.org/10.1016/s1470-2045(17)30376-5
M
Mark Clemons
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
295
Papers
8.3K
Citations
47
h-index
146
i10-index
Mark Clemons is an academic researcher from University of Ottawa. The author has contributed to research in topics: Bone health and treatments & Cancer Diagnosis and Treatment & Breast Cancer Treatment Studies. The author has an h-index of 47, co-authored 251 publications.
ORCID: 0000-0002-0738-2713Papers by this author
worksBuparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
2017 · The Lancet Oncology · 532 citations
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
2009 · Annals of Oncology · 285 citations
https://doi.org/10.1093/annonc/mdp028
Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163
2009 · Journal of Clinical Oncology · 260 citations
https://doi.org/10.1200/jco.2008.21.3033
Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours—a review
2016 · Cancer and Metastasis Reviews · 104 citations
https://doi.org/10.1007/s10555-016-9631-3
O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts
2005 · British Journal of Cancer · 59 citations
https://doi.org/10.1038/sj.bjc.6602833
ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone
2012 · Breast Cancer Research · 52 citations
https://doi.org/10.1186/bcr3361
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat